The value of transgenic models for the study of neurodegenerative diseases

Annals of the New York Academy of Sciences

Volumn 920, Issue , 2000, Pages 179-191

  Price, Donald L ^a   Wong, Philip C ^a   Markowska, Alicja L ^a   Lee, Michael K ^a   Thinakaren, Gopal ^b   Cleveland, Donald W ^c   Sisodia, Sangram S ^c   Borchelt, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN; PRESENILIN 1; PRESENILIN 2; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; CELL DEATH; CONFERENCE PAPER; DEGENERATIVE DISEASE; EXPERIMENTAL MODEL; GENE LOCATION; GENE MUTATION; GENE TARGETING; GENETIC LINKAGE; HUMAN; NERVE CELL DEGENERATION; NEUROPATHY; PATHOGENESIS; TECHNOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0034531646     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06920.x     Document Type: Conference Paper

References (101)

1. From charcot to SOD1: Mechanisms of selective motor neuron death in ALS
2. Genetic classification of primary neurodegenerative disease
3. Alzheimer's disease: Genetic studies and transgenic models
4. Intranuclear inclusions and neuritic pathology in transgenic mice expressing a mutant N-terminal fragment of huntingtin
5. Translating cell biology into therapeutic advances in Alzheimer's disease
6. The genetic and molecular mechanisms of motor neuron disease
7. Genetic neurodegenerative diseases: The human illness and transgenic models
8. β-amyloid precursor protein cleavage by a membrane-bound protease
9. Cleavage of amyloid β peptide during constitutive processing of its precursor
10. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing
11. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
12. Alzheimer's disease: In search of γ-secretase
13. Purification and cloning of amyloid precursor protein beta-secretase from human brain
14. β-Secretase cleavage of Alzheimer's amyloid precusor protein by the transmembrane aspartic protease BACE
15. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
16. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport
17. Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system
18. Alzheimer amyloid protein precursor in the rat hippocampus: Transport and processing through the perforant path
19. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins
20. Amyloid precursor protein in aged nonhuman primates
21. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
22. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid
23. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
24. 717) mutants
25. Protein topology of presenilin 1
26. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
27. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues
28. 299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue
29. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
30. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
31. Amyloid, the presenilins and Alzheimer's disease
32. A vector for expressing foreign genes in the brains and hearts of transgenic mice
33. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
34. Antibody clears senile plaques
35. β-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
36. Skeletal and CNS defects in presenilin-1-deficient mice
37. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm
38. Notch 1 is required for the coordinate segmentation of somites
39. Maintenance of somite borders in mice requires the Delta homologue Dll1
40. Effects of PS1 deficiency on membrane protein trafficking in neurons
41. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
42. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos
43. 1-42/43 expression
44. Natural history and clinical features of amyotrophic lateral sclerosis and related motor neuron diseases
45. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
46. Amyotrophic lateral sclerosis: Insights from genetics
47. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase
48. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
49. Superoxide dismutases
50. Protein oxidation and aging
51. Motor neuron disease caused by mutations in superoxide dismutase 1
52. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene
53. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity
54. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
55. m for hydrogen peroxide
56. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function
57. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells
58. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants
59. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
60. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
61. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
62. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
63. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis
64. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
65. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant
66. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis
67. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis
68. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
69. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
70. The role of copper in neurodegenerative disease
71. The copper chaperone for superoxide dismutase
72. Metal ion chaperone function of the soluble Cu(I) receptor Atxl
73. Delivering copper inside yeast and human cells
74. Genetic and molecular basis for copper toxicity
75. Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice
76. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
77. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation
78. Protective effect of neurofilament NF-H overexpression in motor neuron disease induced by mutant superoxide dismutase
79. Inhibition of ICE slows ALS in mice
80. Neurofilament functions in health and disease
81. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
82. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
83. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis
84. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
85. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein
86. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
87. Pathogenesis of two axonopathies does not require axonal neurofilaments
88. Crystal structure of the copper chaperone for superoxide dismutase
89. Multiple protein domains contribute to the action of the copper chaperone for superoxide dismutase
90. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain
91. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase
92. Age-dependent emergence and progression of a taupathy in transgenic mice overexpressing the shortest human tau isoform
93. Neurodegenerative taupathies: Human disease and transgenic mouse models
94. Expanding our understanding of polyglutamine diseases through mouse models
95. Doxycycline control of prion protein transgene expression modulates prion disease in mice
96. Inducible gene expression in the nervous system of transgenic mice
97. Inducible and reversable gene expression with the rtTA system for the study of memory
98. Immuno-LCM: Laser capture microdissection of immunostained frozen sections for mRNA analysis
99. Real-time quantitative RT-PCR after laser-assisted cell picking
100. Gene expression profiles of laser-capture adjacent neuronal subtypes
101. Laser-capture microdissection: Opening the microscopic frontier to molecular anaysis